China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...

According to Vivek Gupta, vice president of product management at the enterprise application management platform provider AnyPresence, API creation needs to be simple. Gupta, who has a background as a ...

While Bangladesh's pharmaceutical sector has exceeded expectations and surpassed many comparator countries, the industry's reliance on imports for raw materials has long been a limiting factor. At ...

Demand for highly potent APIs continues to rise. Highly potent APIs (HPAPIs) are an increasingly important segment of the API market. While there are many contract development and manufacturing ...

Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...

Organizations continue to develop distributed application ecosystems that send massive populations of containers and microservices into production environments. This means that IT operations teams ...

Watch for the production of active pharmaceutical ingredients (API) to migrate from China and India as Russia, Ukraine and the Baltics ramp up their pharma manufacturing capabilities. Market analyst ...

Bangladesh, a laggard in the production of raw materials for the $3 billion pharmaceuticals industry, has made a four-fold jump in the manufacturing of active pharmaceutical ingredient (API) in the ...

The Active Pharmaceutical Ingredient (API) is the most important part of any drug. The API, as the name would suggest, is the chemical part of any capsule or tablet that works on the disease condition ...